Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography: a Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- Mean pain score during the procedure
研究概览
简要总结
our aims to investigate the effectiveness of10% Lidocaine Spray plus oral celecoxib for Pain Control During Hysterosalpingography
详细描述
hysterosalpingography can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring uterine depth, inserting the cannula; and injection of the dye
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Participant)
盲法说明
randomized controlled trial
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •any patient came for Hysterosalpingography
排除标准
- •any patient has contraindication to Hysterosalpingography
研究组 & 干预措施
Celecoxib plus lidocaine
Celecoxib 200 mg (Celebrex® 200, Pfizer,USA) administered orally 2 h before the procedure +10% lidocaine spray 4 puffs during the procedure
干预措施: celecoxib plus lidocaine (Drug)
Celecoxib
Celecoxib 200 mg (Celebrex® 200, Pfizer,USA) administered orally 2 h before the procedure +Sterile water 4 puffs during the procedure
干预措施: Celecoxib (Drug)
lidocaine
placebo to celecoxib administered orally 2 h before the procedure +10% lidocaine spray 4 puffs during the procedure
干预措施: lidocaine (Drug)
结局指标
主要结局
Mean pain score during the procedure
时间窗: 10 minuets
Assessment of pain using visual analog scale 0-10, 0 = minimum and 10 = maximum scores
次要结局
未报告次要终点
研究者
hany farouk
A Professor
Aswan University Hospital